Compare LLY & KLAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LLY | KLAC |
|---|---|---|
| Founded | 1876 | 1975 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electronic Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0T | 186.0B |
| IPO Year | 2007 | 1994 |
| Metric | LLY | KLAC |
|---|---|---|
| Price | $1,107.84 | $242.93 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 19 | 19 |
| Target Price | $1,218.84 | ★ $1,651.00 |
| AVG Volume (30 Days) | 2.4M | ★ 2.7M |
| Earning Date | 04-30-2026 | 04-29-2026 |
| Dividend Yield | ★ 0.81% | 0.42% |
| EPS Growth | ★ 95.99 | 49.75 |
| EPS | 8.26 | ★ 26.26 |
| Revenue | ★ $65,179,000,000.00 | N/A |
| Revenue This Year | $27.15 | $12.45 |
| Revenue Next Year | $16.04 | $22.33 |
| P/E Ratio | $135.88 | ★ $9.06 |
| Revenue Growth | ★ 44.70 | N/A |
| 52 Week Low | $623.78 | $236.00 |
| 52 Week High | $1,182.73 | $2,431.29 |
| Indicator | LLY | KLAC |
|---|---|---|
| Relative Strength Index (RSI) | 57.53 | 22.61 |
| Support Level | $1,032.70 | N/A |
| Resistance Level | $1,165.92 | $1,179.40 |
| Average True Range (ATR) | 34.45 | 104.98 |
| MACD | -4.64 | -229.52 |
| Stochastic Oscillator | 46.53 | 0.19 |
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
KLA is one of the largest semiconductor wafer fabrication equipment, or WFE, manufacturers in the world. It specializes in the market segment of semiconductor process control, wherein machines inspect semiconductor wafers during research and development and manufacturing for defects and verify precise measurements. In this section of the market, KLA holds a majority share. It also has a small exposure to the etch and deposition segments of the WFE market. It counts as top customers the largest chipmakers in the world, including TSMC and Samsung.